← Back to Search

Oncology Dashboard for Sarcoma Management

N/A

Waitlist Available

Led By Vinod Ravi

Research Sponsored by M.D. Anderson Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Patients with sarcoma on active chemotherapy/targeted therapy

>= 18 years of age

Must not have

Patients with an Eastern Cooperative Oncology Group (ECOG) performance status of 4

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 5 years

Awards & highlights

No Placebo-Only Group

Summary

This trial will test whether a tool called an "oncology dashboard" can help patients and doctors manage cancer treatment better.

Who is the study for?

This trial is for adult sarcoma patients who are not being treated at MDACC but get their follow-up imaging there. They must have been on the same treatment for at least 6 weeks, with stable or mildly progressive disease, and plan to continue it for another 6-8 weeks. They need a history of regular imaging on the affected area and an ECOG performance status better than 4.

What is being tested?

The study tests if using an 'oncology dashboard'—a tool that displays patient cancer treatment data—can help patients understand their condition better and improve how doctors manage care. It involves best practices, questionnaires, and informational interventions.

What are the potential side effects?

Since this trial focuses on information management rather than medication or invasive procedures, traditional side effects like those seen with drugs are not expected. However, there may be indirect effects related to changes in patient understanding or clinical decision-making.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am currently receiving chemotherapy or targeted therapy for sarcoma.

Select...

I am 18 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I am unable to walk or care for myself.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 5 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 5 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Group I: Group II (standard of care)Experimental Treatment2 Interventions

Patients receive standard of care.

Group II: Group I (oncology dashboard)Experimental Treatment2 Interventions

Radiologist records information from patient's recent scan into oncology dashboard. Patients view images of how disease may have changed over time on oncology dashboard.

0 / 3Eligibility criteria met